No Data
No Data
BioAffinity BIAF Earnings; Tharimmune THAR Pre-IND Update
Tharimmune Says FDA Requires No Additional Trials of TH104 Against Opioid Exposure
Tharimmune | 10-K: FY2024 Annual Report
Tharimmune Announce Preclinical TH023 Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Tharimmune: Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-Alpha